Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Techno9 Indonesia Tbk. (NINE)

UBC Medical Indonesia Tbk.Trading
Techno9 Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Techno9 Indonesia Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Techno9 Indonesia Tbk. diperdagangkan di Rp78 (kapitalisasi pasar 166,09 M, volume 24 jam 4,9 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 3,5× kapitalisasi pasar Techno9 Indonesia Tbk., dan Techno9 Indonesia Tbk. lebih aktif diperdagangkan (4,9 jt vs 3,48 jt). Mana yang lebih baik tergantung tujuan investasimu.

LABSNINE
Kapitalisasi Pasar
576,7 M166,09 M
Volume
3,48 jt4,9 jt
Lot
34,82 rb49,03 rb
Perputaran
522,79 jt380,63 jt
Harga Rata-rata
150,1377,63
Nilai Transaksi
522,79 jt380,63 jt
Harga Ekuilibrium Indikatif
14878
Volume Ekuilibrium Indikatif
350175

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
NINE
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Techno9 Indonesia Tbk.

PT Techno9 Indonesia,Tbk (the"Company")wasestablished based on Deed No. 05 dated June 9, 2010, whichwasmade before Notary Lidya Enywati Tjendra, S.H. The Company started its commercial operations since June 23, 2010

Selengkapnya di halaman NINE